This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

4 Stocks Rising on Unusual Volume

Endo Health Solutions

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Endo Health Solutions (ENDP - Get Report) is a specialty pharmaceutical company engaged in the research, development, sale and marketing of branded and generic prescription pharmaceuticals used to treat and manage pain. This stock is trading up 8.4% at $30.40 in recent trading.

Today's Volume: 8.14 million

Average Volume: 2.33 million

Volume % Change: 370%

>>5 Health Care Stocks Triggering 'Buys'

Shares of ENDP are skyrocketing higher today after Wells Fargo said it believes the appointment of new CEO Rajiv De Silva suggests the company does not intend to sell itself in the near-term, contrary to a Reuters report in January. Wells Fargo has a market perform rating on the stock.

From a technical perspective, ENDP is bouncing strongly here off its 50-day moving average of $27.75 and its moving back above its 200-day moving average of $29.93 with massive upside volume. This move has broken the downtrend shares of ENDP have been in during the last month, since shares dropped from its recent high of $33.32 to its low of $27.70. During that move, shares of ENDP were consistently making lower highs and lower lows, which is bearish technical price action.

Traders should now look for long-biased trades in ENDP as long as it's trending above its 200-day at $29.93, and then once it sustains a move or close above its next major breakout levels at $33.32 to $33.86 with volume that hits near or above 2.33 million shares. If that breakout triggers soon, then ENDP will set up to re-test or possibly take out its next major overhead resistance levels at $35.60 to $36.30.
2 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
ACTG $4.82 0.00%
APO $16.91 0.00%
BKS $11.75 0.00%
ENDP $27.00 0.00%
AAPL $93.74 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs